Ligand Pharmaceuticals Inc (NAS:LGND)
$ 81.36 -1.01 (-1.23%) Market Cap: 1.46 Bil Enterprise Value: 1.16 Bil PE Ratio: 15.29 PB Ratio: 1.81 GF Score: 76/100

Ligand Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 04, 2021 / 03:30PM GMT
Release Date Price: $71.95 (+2.09%)
Operator

Good morning, and welcome to the Annual Meeting of Shareholders of Ligand Pharmaceuticals Incorporated. Please note that today's meeting is being recorded. (Operator Instructions)

It's now my pleasure to turn today's meeting over to Mr. Charles Berkman, Senior Vice President, General Counsel and Secretary of Ligand. Mr. Berkman, the floor is yours.

Charles S. Berkman
Ligand Pharmaceuticals Incorporated - Senior VP, General Counsel & Secretary

Welcome to Ligand's annual meeting. I am Charles Berkman, Ligand's General Counsel, and I will act as Chairman and Secretary for this meeting.

We are hosting this year's annual meeting in a virtual-only format. If you encounter any technical difficulties accessing or participating in the meeting, please refer to the support link on the virtual meeting website for information on how to reach your support team.

Computershare, represented by Mark Cano, will act as the inspector of elections. Also attending today's meeting is Emma Epes from Ernst & Young LLP, the company's independent

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot